Approval Date: 06/27/2014.

How long has afrezza been on the market?

On June 27, 2014, the FDA approved Afrezza, an inhaled insulin for mealtime use, bringing this form of therapy back to the market after a 7-year absence.

When was inhaled insulin approved by the FDA?

June 27, 2014 — The FDA has approved inhaled insulin to treat type 1 and type 2 diabetes. The insulin, called Afrezza, is a rapid-acting insulin and is meant to be taken at mealtime or soon after.